Assay Detail
Functional
CHEMBL935846
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Antiviral activity against HIV1 BaL R5 subtype B in phytohemagglutininin-activated PBMCs assessed as inhibition of p24 Gag protein expression by MTT assay
9
Total Activities
9
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Functional |
| Organism | Human immunodeficiency virus 1 |
| Confidence | 1 — Organism |
| Curated By | Intermediate |
Target
Human immunodeficiency virus 1 (CHEMBL378) ↗| Type | ORGANISM |
| Organism | Human immunodeficiency virus 1 |
Publication
A novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI), GRL-98065, is potent against multiple-PI-resistant human immunodeficiency virus in vitro.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| EC50 | 9 | 8.20 | 9.70 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL178593 | — | — | 1 | 9.70 |
| CHEMBL1163 | ATAZANAVIR | 4.0 | 1 | 8.89 |
| CHEMBL729 | LOPINAVIR | 4.0 | 1 | 8.28 |
| CHEMBL114 | SAQUINAVIR | 4.0 | 1 | 8.08 |
| CHEMBL584 | NELFINAVIR | 4.0 | 1 | 7.75 |
| CHEMBL5483011 | INDINAVIR | 3.0 | 1 | 7.66 |
| CHEMBL163 | RITONAVIR | 4.0 | 1 | 7.64 |
| CHEMBL116 | AMPRENAVIR | 4.0 | 1 | 7.60 |
| CHEMBL1323 | DARUNAVIR | 4.0 | 1 | - |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL178593 | — | EC50 | = | 0.2 | nM | 9.70 |
| CHEMBL1163 | ATAZANAVIR | EC50 | = | 1.3 | nM | 8.89 |
| CHEMBL729 | LOPINAVIR | EC50 | = | 5.3 | nM | 8.28 |
| CHEMBL114 | SAQUINAVIR | EC50 | = | 8.3 | nM | 8.08 |
| CHEMBL584 | NELFINAVIR | EC50 | = | 18.0 | nM | 7.75 |
| CHEMBL5483011 | INDINAVIR | EC50 | = | 22.0 | nM | 7.66 |
| CHEMBL163 | RITONAVIR | EC50 | = | 23.0 | nM | 7.64 |
| CHEMBL116 | AMPRENAVIR | EC50 | = | 25.0 | nM | 7.60 |
| CHEMBL1323 | DARUNAVIR | EC50 | - | — | - |